Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$-648.13M
↓ 121% vs avg
Percentile
P0
Near historical low
Streak
6 yr
Consecutive declineContracting
Average
$-293.25M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-648.13M | -35.3% |
| 2024 | $-479.00M | -36.8% |
| 2023 | $-350.06M | -42.5% |
| 2022 | $-245.73M | -34.4% |
| 2021 | $-182.78M | -116.0% |
| 2020 | $-84.61M | -35.5% |
| 2019 | $-62.44M | - |